Market Overview

Aptose Biosciences Receives Orphan Drug Designation By FDA For Phenanthroline Treatment Of Acute Myeloid Leukemia

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News FDA

 

Related Articles (APTO)